Company Overview

Company name: Stark Therapeutics
Description: Developer of different therapies intended to work on adeno-associated viral based gene for chronic diseases like type II diabetes. The company’s therapies include preclinical testing, clinical trials enabling patients to get advanced treatment in diagnosing different diseases.
Year founded: 2018
Parent company:
Industry: Healthcare | Group: | Code:
Website: www.stark-tx.com
Employees: 1
City: Carlsbad
State: California
Country: United States
Region:

Financial Highlights

Start up capital raised (USD Million): 0.00
Business status: Generating Revenue
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status:
Number of active investors:
Profile last updated: 10-Aug-2020
Last known valuation: 7.00
Last known valuation date: 23-Jul-2020